Much Ado About Nothing Much With Atara's MS Hopeful

Interim Analysis On ATA188 Reveals Little

 
• By Kevin Grogan
  
2023
Atara builds towards a successful 2023 when its multiple sclerosis data will read out • Source: Shutterstock

More from Clinical Trials

More from R&D